Status:
COMPLETED
Brief Anxiety Skills Training Intervention for Veterans in Primary Care
Lead Sponsor:
VA Office of Research and Development
Conditions:
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Anxiety symptoms are common among primary care patients, but anxiety is undertreated. Brief behavioral (non-medication) anxiety treatments are needed. The purpose of this study is to evaluate whether ...
Detailed Description
Background/Rationale: Many Veteran primary care patients experience impairing symptoms of anxiety, but rates of behavioral treatment are low. Primary Care-Mental Health Integration (PCMHI), in which m...
Eligibility Criteria
Inclusion
- Veteran,
- Age \>=18 years,
- Seen in the Syracuse or Western New York VAMC or CBOC primary care clinic in the past 12 months,
- Screen positive for current (past 2 weeks) clinically significant anxiety symptoms (\>= 8 on GAD7)
Exclusion
- Inability to communicate in English (as assessed by study staff);
- Hearing impairment that precludes completion of telephone eligibility screening (as assessed by study staff);
- Cognitive impairment that precludes informed consent, defined as any of the following:
- not able to comprehend the study description or eligibility screening as assessed by study staff,
- diagnosis of dementia or severe cognitive impairment per self-report, primary care provider, or Problem List, or
- screen positive for cognitive impairment (\>= 3 errors on screener);
- Diagnosis of Obsessive-Compulsive Disorder (OCD) or serious mental illness (SMI, i.e., psychotic disorders, bipolar disorder) in Problem List;
- Encounter diagnosis of Posttraumatic Stress Disorder (PTSD) within the past 2 years or screen positive for PTSD (\>= 4 for men or \>= 5 for women on the Primary Care PTSD Screen for DSM-5;
- Currently in psychotherapy/counseling for anxiety and/or depression, defined as any of the following within the past 30 days:
- attending \>= 1 non-intake specialty mental health session,
- attending \>= 2 PCMHI sessions, or
- being hospitalized for mental health treatment;
- Current (past 2 weeks) severe depressive symptoms (\>= 20 on PHQ9);
- At imminent risk of suicide, defined as being in need of intensive treatment (e.g., hospitalization) to ensure safety, based on study staff's suicide risk assessment (verified by the PI);
- Started or had dosage change in psychotropic medication for anxiety or depression in the past 30 days
Key Trial Info
Start Date :
August 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT04829240
Start Date
August 17 2021
End Date
August 31 2025
Last Update
September 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Western New York Healthcare System, Buffalo, NY
Buffalo, New York, United States, 14215-1129
2
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, United States, 13210-2716